FDx Advisors’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,731
| Closed | -$274K | – | 610 |
|
|
2023
Q4 | $274K | Sell |
12,731
-1,317
| -9% | -$28.3K | 0.02% | 545 |
|
|
2023
Q3 | $261K | Sell |
14,048
-7,517
| -35% | -$140K | 0.02% | 523 |
|
|
2023
Q2 | $546K | Buy |
21,565
+4,697
| +28% | +$119K | 0.03% | 428 |
|
|
2023
Q1 | $399K | Hold |
16,868
| – | – | 0.02% | 471 |
|
|
2022
Q4 | $399K | Buy |
16,868
+1,373
| +9% | +$32.5K | 0.02% | 471 |
|
|
2022
Q3 | $393K | Buy |
15,495
+1,765
| +13% | +$44.8K | 0.02% | 467 |
|
|
2022
Q2 | $456K | Buy |
13,730
+1,893
| +16% | +$62.9K | 0.02% | 505 |
|
|
2022
Q1 | $854K | Buy |
11,837
+3,816
| +48% | +$275K | 0.03% | 359 |
|
|
2021
Q4 | $736K | Sell |
8,021
-212
| -3% | -$19.5K | 0.02% | 426 |
|
|
2021
Q3 | $1.04M | Buy |
8,233
+769
| +10% | +$97.5K | 0.03% | 326 |
|
|
2021
Q2 | $1.24M | Buy |
7,464
+1,085
| +17% | +$180K | 0.04% | 287 |
|
|
2021
Q1 | $1.16M | Sell |
6,379
-2,656
| -29% | -$483K | 0.04% | 269 |
|
|
2020
Q4 | $1.81M | Buy |
9,035
+3,354
| +59% | +$671K | 0.07% | 175 |
|
|
2020
Q3 | $1.25M | Buy |
5,681
+4,100
| +259% | +$899K | 0.06% | 204 |
|
|
2020
Q2 | $302K | Sell |
1,581
-842
| -35% | -$161K | 0.02% | 443 |
|
|
2020
Q1 | $376K | Buy |
2,423
+11
| +0.5% | +$1.71K | 0.02% | 347 |
|
|
2019
Q4 | $202K | Buy |
+2,412
| New | +$202K | 0.01% | 593 |
|
|
2019
Q3 | – | Sell |
-10,781
| Closed | -$716K | – | 787 |
|
|
2019
Q2 | $716K | Buy |
10,781
+1,783
| +20% | +$118K | 0.03% | 401 |
|
|
2019
Q1 | $500K | Buy |
+8,998
| New | +$500K | 0.02% | 465 |
|